Pariente Antoine, Dartigues Jean-Francois, Benichou Jacques, Letenneur Luc, Moore Nicholas, Fourrier-Réglat Annie
Institut National de la Santé et la Recherche Médicale (INSERM), U657, Bordeaux, France.
Drugs Aging. 2008;25(1):61-70. doi: 10.2165/00002512-200825010-00007.
Benzodiazepines are frequently used medications in the elderly, in whom they are associated with an increased risk of falling, with sometimes dire consequences.
To estimate the impact of benzodiazepine-associated injurious falls in a population of elderly persons.
A nested case-control study was conducted using data collected during 10 years of follow-up of the French PAQUID (Personnes Agées QUID) community-based cohort. The main outcome measure was the occurrence of an injurious fall, which was defined as a fall resulting in hospitalization, fracture, head trauma or death. Controls (3 : 1) were frequency-matched to cases. Benzodiazepine exposure was the use of benzodiazepines over the previous 2 weeks reported at the follow-up visit preceding the fall.
Benzodiazepine use was significantly associated with the occurrence of injurious falls, with a significant interaction with age. The adjusted odds ratio for injurious falls in subjects exposed to benzodiazepines was 2.2 (95% CI 1.4, 3.4) in subjects aged > or = 80 years and 1.3 (95% CI 0.9, 1.9) in subjects aged <80 years. The population attributable risk for injurious falls in subjects exposed to benzodiazepines was 28.1% (95% CI 16.7, 43.2) for subjects aged > or =80 years. The incidence of injurious falls in subjects aged > or = 80 years exposed to benzodiazepines in the PAQUID cohort was 2.8/100 person-years. Over 9% of these falls were fatal. According to these results and to recent population estimates, benzodiazepine use could be held responsible for almost 20 000 injurious falls in subjects aged > or = 80 years every year in France, and for nearly 1800 deaths.
Given the considerable morbidity and mortality associated with benzodiazepine use and the fact that existing good practice guidelines on benzodiazepines have not been effective in preventing their misuse (possibly because they have not been applied), new methods for limiting use of benzodiazepines in the elderly need to be found.
苯二氮䓬类药物在老年人中经常使用,而在他们身上,此类药物与跌倒风险增加相关,有时会产生严重后果。
评估苯二氮䓬类药物相关的伤害性跌倒对老年人群的影响。
采用法国PAQUID(老年人群队列研究)社区队列10年随访期间收集的数据进行巢式病例对照研究。主要结局指标是伤害性跌倒的发生情况,其定义为导致住院、骨折、头部创伤或死亡的跌倒。对照(3:1)与病例进行频率匹配。苯二氮䓬类药物暴露是指在跌倒前的随访中报告的过去2周内使用苯二氮䓬类药物的情况。
使用苯二氮䓬类药物与伤害性跌倒的发生显著相关,且与年龄存在显著交互作用。在年龄≥80岁的受试者中,暴露于苯二氮䓬类药物的受试者发生伤害性跌倒的调整优势比为2.2(95%可信区间1.4, 3.4),而在年龄<80岁的受试者中为1.3(95%可信区间0.9, 1.9)。在年龄≥80岁的受试者中,暴露于苯二氮䓬类药物的人群归因危险度为28.1%(95%可信区间16.7, 43.2)。在PAQUID队列中,年龄≥80岁且暴露于苯二氮䓬类药物的受试者中伤害性跌倒的发生率为2.8/100人年。这些跌倒中有超过9%是致命的。根据这些结果以及近期的人群估计,在法国,每年使用苯二氮䓬类药物可能导致年龄≥80岁的受试者中近20000次伤害性跌倒,并导致近1800人死亡。
鉴于使用苯二氮䓬类药物会带来相当高的发病率和死亡率,且现有的关于苯二氮䓬类药物的良好实践指南未能有效防止其滥用(可能是因为未得到应用),需要找到限制老年人使用苯二氮䓬类药物的新方法。